Alzheimer’s Disease

Alzheimer’s Disease

Inflammation in Alzheimer’s disease: what we know and what’s to come 1:03
Inflammation in Alzheimer’s disease: what we know and what’s to come
Michael Heneka
Improving animal models in Alzheimer’s disease research 1:59
Improving animal models in Alzheimer’s disease research
Michael Heneka
Neurological effects of COVID-19: looking at previous data 1:53
Neurological effects of COVID-19: looking at previous data
Michael Heneka
Dementia and stress: the challenges 1:01
Dementia and stress: the challenges
Luiza Spiru
Dementia, stress and the molecular age of the brain 3:08
Dementia, stress and the molecular age of the brain
Luiza Spiru
Are biomarkers for Alzheimer’s disease ready for clinical practice? 2:25
Are biomarkers for Alzheimer’s disease ready for clinical practice?
Giancarlo Logroscino
Defining Alzheimer’s disease: clinical or biological 2:22
Defining Alzheimer’s disease: clinical or biological
Bart De Strooper
Cross neurodegenerative disease genetic analysis: similarities and differences 2:20
Cross neurodegenerative disease genetic analysis: similarities and differences
John Hardy
Hopeful developments for Alzheimer’s Disease 1:21
Hopeful developments for Alzheimer’s Disease
Bart De Strooper
The future of Alzheimer’s disease: aducanumab 2:38
The future of Alzheimer’s disease: aducanumab
John Hardy
The benefits of GWAS in understanding Alzheimer’s disease 2:00
The benefits of GWAS in understanding Alzheimer’s disease
John Hardy
Therapeutic development in Alzheimer’s disease and the lack of funding 2:02
Therapeutic development in Alzheimer’s disease and the lack of funding
Bart De Strooper
The potential of biomarkers in dementia 3:08
The potential of biomarkers in dementia
Giancarlo Logroscino
Identifying new therapeutic targets for neurodegenerative diseases 1:34
Identifying new therapeutic targets for neurodegenerative diseases
Bart De Strooper
The under-representation of females in research: impact in drug development 1:53
The under-representation of females in research: impact in drug development
Christina Dalla
Gut microbiota as a potential therapeutic target in Huntington’s disease 2:01
Gut microbiota as a potential therapeutic target in Huntington’s disease
Anthony Hannan
The content of VJNeurology is intended for healthcare professionals